Summary Coal tar, a tumour initiator, and dithranol, a tumour promoter, are used in the treatment of psoriasis. Topical treatment of mice with pharmaceutical formulations of these two agents, at therapeutic doses, induced skin papillomas in a classical two-stage carcinogenesis protocol, while treatment with either agent alone did not. This finding has implications for the use of both agents in combination in the treatment of psoriasis.
It is estimated that 2-3% of people in Britain suffer from psoriasis. Many of the remedies for this chronic skin condition have demonstrable genotoxic effects in experimental animals and in in vitro assays (Bridges et al., 1981) . The evidence for carcinogenicity in humans of individual therapies remains, at best, equivocal (Pittelkow et al., 1981; Wolff, 1990) , although excesses of skin cancer have been observed with combination therapies, for example UV light and coal tar (Stern et al., 1980) .
Coal tar is rich in polycyclic aromatic hydrocarbons, many of which are potent skin carcinogens and tumour initiators. Evidence of DNA damage, in the form of aromatic adducts, has been detected in both mouse and human skin, and also in mouse internal organs, following topical application of coal tar (Schoket et al., 1988 (Schoket et al., , 1990 . Dithranol (anthralin), while not carcinogenic in itself, has been shown to act as a promoter of the growth of tumours initiated by other agents (Bock & Burns, 1963; Viluksela et al., 1986) . Therefore, the possibility exists that patients previously treated with coal tar and subsequently using dithranol are being subjected to a two-stage carcinogenicity protocol akin to the classic mouse skin model (Berenblum, 1982) .
Materials and methods
In order to determine the potential of treatment with coal tar ointment followed by dithranol to be tumorigenic, the following study was performed. Female CD-1 mice, aged 7-8 weeks, were treated topically five times weekly (Monday to Friday, inclusive) with 1.5% coal tar ointment (Lorinden) ('initiator', 50 mg per treatment) for 2 weeks, and then with 0.1 % dithranol cream ('promoter', 50 Tumours > 1 mm diameter were scored. The animals were killed by cervical dislocation and subjected to post-mortem examination. The skin of the dorsal region was removed and areas containing lesions were excised. These, together with organs having an abnormal appearance, were placed in 10% (v/v) buffered formalin, embedded in paraffin wax, sectioned, stained with haemotoxylin and eosin and examined microscopically.
In addition, groups of four mice were treated with coal tar for 2 weeks or benzo[a]pyrene (single dose) as described above, or untreated, and were killed 9 days after treatment with BP and 12 days after the final application of coal tar. Another group was given three doses of dithranol (on alternate days, as described above) and killed 3 days after the final dose. DNA was isolated from the treated areas of epidermis, hydrolysed enzymically to nucleoside 3'-monophosphates and then 32P-post-labelled by incubation with T4 polynucleotide kinase and [7_-32P]ATP as previously described (Phillips et al., 1986; Schoket et al., 1988 ). The DNA digests were then subjected to multidirectional thin-layer chromatography (TLC) on polyethyleneimine (PEI)-cellulose and the presence of DNA adducts was detected by autoradiography (Phillips et al., 1986) .
Survival plots of time to tumour were calculated using the Kaplan-Meier method (Kaplan & Meier, 1958) . The statistical significance of results was determined by the log-rank test.
Results and discussion
The chromatograms obtained when digests of DNA from mouse skin that had been treated with coal tar or BP confirmed the DNA-binding activity of these agents. In the case of BP, a single major adduct spot and a number of very minor ones were detected (Figure lb) . With DNA from coal tar-treated mice, a series of adduct spots in a diagonal band was observed (Figure la) , indicative of DNA binding by a number of different polycyclic aromatic hydrocarbons, and similar to adduct patterns induced by similar complex mixtures (Schoket et al., 1988 (Schoket et al., , 1990 . No adduct spots were detected in mice that were not treated with an initiator (Figure lc) . The chromatograms of DNA from mice treated with dithranol were identical to those of DNA from untreated mice, confirming that dithranol does not form DNA adducts in vivo (data not shown). We have previously reported the absence of DNA adduct formation by dithranol in human skin treated in organ culture (Schoket et al., 1990) .
The results of the tumorigenicity experiments are shown in Table I and Figure 2 . None of the mice treated with coal tar or dithranol alone developed tumours during the experiment. However, four mice (15% of survivors) that had received coal tar followed by dithranol developed papillomas (1 -2 mm) (significantly different from groups receiving coal tar or dithranol alone; see Table II) , and 12 (44%) had and killed 9 days later. c, Skin DNA from untreated mice. The DNA adducts were resolved by multidirectional chromatography using urea-containing solvents (Phillips et al., 1986 
